T2D patients
Beta-cell inflammation
beta-cell function
beta cells
continuous beta-cell
pancreas inflammation
control patients
dysfunction
impaired insulin action
bacterial translocation Type
increased bacterial load
adipose tissue inflammation
increased translocation of detrimental bacteria
impaired function
effects effects
exogenous insulin therapy
destruction
inflammatory process
detrimental process
addition
inflammatory response
pancreatic tissue
infiltration of immune cells
TLR related mechanisms
glucose metabolism
central role
islets of Langerhans
treatment
pancreatectomy
obese mouse model
epidemic proportions
primary trigger
major morbidity
gavage studies
toll
knockout
diabetes
leaky gut
intestinal microbiota composition
alterations
mortality
receptors
DNA
TRL4
resistance
progressive course of disease
hypothesis
translocated microorganism
involved micro organisms
cause
hyperglycemia
pilot data
highest pathogenicity
therapies
diet